000181110 001__ 181110
000181110 005__ 20240229152741.0
000181110 0247_ $$2doi$$a10.1016/j.exphem.2022.07.302
000181110 0247_ $$2pmid$$apmid:35952718
000181110 0247_ $$2ISSN$$a0301-472X
000181110 0247_ $$2ISSN$$a1873-2399
000181110 037__ $$aDKFZ-2022-01779
000181110 041__ $$aEnglish
000181110 082__ $$a610
000181110 1001_ $$aDannenmann, Benjamin$$b0
000181110 245__ $$aCorrigendum to 'Human iPSC-based model of severe congenital neutropenia reveals elevated UPR and DNA damage in CD34+ cells preceding leukemic transformation' <[Experimental Hematology, Volume 71, 2019;71:51-60]>.
000181110 260__ $$aAmsterdam [u.a.]$$bElsevier Science$$c2022
000181110 3367_ $$2DRIVER$$aarticle
000181110 3367_ $$2DataCite$$aOutput Types/Journal article
000181110 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1665146265_4147$$xErratum/Correction
000181110 3367_ $$2BibTeX$$aARTICLE
000181110 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000181110 3367_ $$00$$2EndNote$$aJournal Article
000181110 500__ $$a2022 Oct;114:61
000181110 536__ $$0G:(DE-HGF)POF4-899$$a899 - ohne Topic (POF4-899)$$cPOF4-899$$fPOF IV$$x0
000181110 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000181110 7001_ $$aZahabi, Azadeh$$b1
000181110 7001_ $$0P:(DE-He78)bc2e8b2ac93b02432d1816f80e26e7e8$$aMir, Perihan$$b2
000181110 7001_ $$aOswald, Benedikt$$b3
000181110 7001_ $$aBernhard, Regine$$b4
000181110 7001_ $$aKlimiankou, Maksim$$b5
000181110 7001_ $$aMorishima, Tatsuya$$b6
000181110 7001_ $$0P:(DE-He78)3fc9ad1c0cc7a2172b86374faed6edea$$aSchulze-Osthoff, Klaus$$b7$$udkfz
000181110 7001_ $$aZeidler, Cornelia$$b8
000181110 7001_ $$aKanz, Lothar$$b9
000181110 7001_ $$aLachmann, Nico$$b10
000181110 7001_ $$aMoritz, Thomas$$b11
000181110 7001_ $$aWelte, Karl$$b12
000181110 7001_ $$aSkokowa, Julia$$b13
000181110 773__ $$0PERI:(DE-600)2005403-8$$a10.1016/j.exphem.2022.07.302$$gp. S0301472X2200580X$$p61$$tExperimental hematology$$v114$$x0301-472X$$y2022
000181110 909CO $$ooai:inrepo02.dkfz.de:181110$$pVDB
000181110 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)bc2e8b2ac93b02432d1816f80e26e7e8$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000181110 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)3fc9ad1c0cc7a2172b86374faed6edea$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000181110 9131_ $$0G:(DE-HGF)POF4-899$$1G:(DE-HGF)POF4-890$$2G:(DE-HGF)POF4-800$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$vohne Topic$$x0
000181110 9141_ $$y2022
000181110 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-01-28
000181110 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2021-01-28
000181110 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-01-28
000181110 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2022-11-08$$wger
000181110 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bEXP HEMATOL : 2021$$d2022-11-08
000181110 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-08
000181110 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-08
000181110 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2022-11-08
000181110 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2022-11-08
000181110 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-08
000181110 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-08
000181110 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2022-11-08
000181110 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2022-11-08
000181110 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2022-11-08
000181110 9201_ $$0I:(DE-He78)L801-20160331$$kL801$$lDKTK Tübingen$$x0
000181110 980__ $$ajournal
000181110 980__ $$aVDB
000181110 980__ $$aI:(DE-He78)L801-20160331
000181110 980__ $$aUNRESTRICTED